Changes in bile acids, FGF-19 and sterol absorption in response to bile salt hydrolase active L. reuteri NCIMB 30242

Reference List

• Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006; 439:484-9; PMID:16400329; http://dx.doi.org/10.1038/nature04330
   PubMed Web of Science ®Google Scholar
• Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, Moore DD, Auwerx J. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 2004; 113:1408-18; PMID:15146238; http://dx.doi.org/10.1172/JCI21025
   PubMed Web of Science ®Google Scholar
• Houten SM, Watanabe M, Auwerx J. Endocrine functions of bile acids. EMBO J 2006; 25:1419-25; PMID:16541101; http://dx.doi.org/10.1038/sj.emboj.7601049
   PubMed Web of Science ®Google Scholar
• Pols TW, Noriega LG, Nomura M, Auwerx J, Schoonjans K. The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol 2011:54: 1263-72; PMID:21145931; http://dx.doi.org/10.1016/j.jhep.2010.12.004
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. Bile acids and the gut microbiome. Curr Opin Gastroenterol 2014; 30:332-8; PMID:24625896; http://dx.doi.org/10.1097/MOG.0000000000000057
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation. Physiol Rev 2009; 89:147-91; PMID:19126757; http://dx.doi.org/10.1152/physrev.00010.2008
   PubMed Web of Science ®Google Scholar
• Patti ME, Houten SM, Bianco AC, Bernier R, Larsen PR, Holst JJ, Badman MK, Maratos-Flier E, Mun EC, Pihlajamaki J, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity 2009; 17:1671-7; PMID:19360006; http://dx.doi.org/10.1038/oby.2009.102
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Alves JM, Hylemon PB, Bajaj JS. Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship. Gut Microbes 2013; 4:382-7; PMID:23851335; http://dx.doi.org/10.4161/gmic.25723
   PubMed Web of Science ®Google Scholar
• Duboc H, Rajca S, Rainteau D, Benarous D, Maubert MA, Quervain E, Thomas G, Barbu V, Humbert L, Despras G, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 2012; 62:531-9; PMID:22993202; http://dx.doi.org/10.1136/gutjnl-2012-302578
   PubMedGoogle Scholar
• Duboc H, Rainteau D, Rajca S, Humbert L, Farabos D, Maubert M, Grondin V, Jouet P, Bouhassira D, Seksik P, et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2012; 24:513-7; PMID:22356587; http://dx.doi.org/10.1111/j.1365-2982.2012.01893.x
   PubMed Web of Science ®Google Scholar
• Matsubara T, Li F, Gonzalez FJ. FXR signaling in the enterohepatic system. Mol Cell Endocrinol 2013; 368:17-29; PMID:22609541; http://dx.doi.org/10.1016/j.mce.2012.05.004
   PubMed Web of Science ®Google Scholar
• Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, Macchiarulo A, Yamamoto H, Mataki C, Pruzanski M, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009; 10:167-77; PMID:19723493; http://dx.doi.org/10.1016/j.cmet.2009.08.001
   PubMed Web of Science ®Google Scholar
• Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500:541-6; PMID:23985870; http://dx.doi.org/10.1038/nature12506
   PubMed Web of Science ®Google Scholar
• Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sorensen SJ, Hansen LH, Jakobsen M. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010; 5:e9085; PMID:20140211; http://dx.doi.org/10.1371/journal.pone.0009085
   PubMedGoogle Scholar
• Peterson DA, Frank DN, Pace NR, Gordon JI. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 2008; 3:417-27; PMID:18541218; http://dx.doi.org/10.1016/j.chom.2008.05.001
   PubMed Web of Science ®Google Scholar
• Ogilvie LA, Jones BV. Dysbiosis modulates capacity for bile acid modification in the gut microbiomes of patients with inflammatory bowel disease: a mechanism and marker of disease? Gut 2012; 61:1642-3; PMID:22490526; http://dx.doi.org/10.1136/gutjnl-2012-302137
   PubMed Web of Science ®Google Scholar
• Labbé A, Ganopolsky JG, Martoni CJ, Prakash S, Jones ML. Bacterial bile metabolising gene abundance in the Crohn's, ulcerative colitis and type 2 diabetes metagenome. PLoS One 2014; 9:e115175; PMID: 25517115
   Google Scholar
• Jones BV, Begley M, Hill C, Gahan CG, Marchesi JR. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A 2008; 105:13580-5; PMID:18757757; http://dx.doi.org/10.1073/pnas.0804437105
   PubMed Web of Science ®Google Scholar
• Joyce SA, MacSharry J, Casey PG, Kinsella M, Murphy EF, Shanahan F, Hill C, Gahan CG. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc Natl Acad Sci U S A 2014; 111:7421-6; PMID:24799697; http://dx.doi.org/10.1073/pnas.1323599111
   PubMed Web of Science ®Google Scholar
• Jones ML, Martoni CJ, Parent M, Prakash S. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br J Nutr 2012; 107:1505-13; PMID:22067612; http://dx.doi.org/10.1017/S0007114511004703
   PubMedGoogle Scholar
• Jones ML, Martoni CJ, Prakash S. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial. Eur J Clin Nutr 2012; 66:1234-41; PMID:22990854; http://dx.doi.org/10.1038/ejcn.2012.126
   PubMed Web of Science ®Google Scholar
• Ooi LG, Ahmad R, Yuen KH, Liong MT. Lactobacillus gasseri CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters. J Dairy Sci 2010; 93: 5048-58:PMID:20965319; http://dx.doi.org/10.3168/jds.2010-3311
   PubMed Web of Science ®Google Scholar
• Holt JA, Luo G, Billin AN, Bisi J, McNeill YY, Kozarsky KF, Donahee M, Wang DY, Mansfield TA, Kliewer SA, et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 2003; 17:1581-91 PMID:12815072; http://dx.doi.org/10.1101/gad.1083503
   PubMed Web of Science ®Google Scholar
• Miettinen TA, Gylling H, Nissinen MJ. The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption. Nutr Metab Cardiovasc Dis 2011; 21:765-9; PMID:21899991; http://dx.doi.org/10.1016/j.numecd.2011.05.005
   PubMedGoogle Scholar
• Schiff ER, Small NC, Dietschy JM. Characterization of the kinetics of the passive and active transport mechanisms for bile acid absorption in the small intestine and colon of the rat. J Clin Invest 1972; 51:1351-62; PMID:5024036; http://dx.doi.org/10.1172/JCI106931
   PubMed Web of Science ®Google Scholar
• Fang F, Li Y, Bumann M, Raftis EJ, Casey PG, Cooney JC, Walsh MA, O'Toole PW. Allelic variation of bile salt hydrolase genes in Lactobacillus salivarius does not determine bile resistance levels. J Bacteriol 2009; 191:5743-57; PMID:19592587; http://dx.doi.org/10.1128/JB.00506-09
   PubMed Web of Science ®Google Scholar
• Gaull GE, Pasantes-Morales H, Wright CE. Taurine in human nutrition: overview. Prog Clin Biol Res 1985; 179:3-21; PMID:3903756
   PubMedGoogle Scholar
• Grill JP, Cayuela C, Antoine JM, Schneider F. Isolation and characterization of a Lactobacillus amylovorus mutant depleted in conjugated bile salt hydrolase activity: relation between activity and bile salt resistance. J Appl Microbiol 2000; 89:553-63; PMID:11054157; http://dx.doi.org/10.1046/j.1365-2672.2000.01147.x
   PubMed Web of Science ®Google Scholar
• Abumrad NA, Davidson NO. Role of the gut in lipid homeostasis. Physiol Rev 2012; 92:1061-85; PMID:22811425; http://dx.doi.org/10.1152/physrev.00019.2011
   PubMed Web of Science ®Google Scholar
• Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, Hobbs HH. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 2002; 110: 671-80:PMID:12208868; http://dx.doi.org/10.1172/JCI0216001
   PubMed Web of Science ®Google Scholar
• Ockene IS, Chiriboga DE, Stanek EJ, III, Harmatz MG, Nicolosi R, Saperia G, Well AD, Freedson P, Merriam PA, Reed G, et al. Seasonal variation in serum cholesterol levels: treatment implications and possible mechanisms. Arch Intern Med 2004; 164:863-70; PMID:15111372; http://dx.doi.org/10.1001/archinte.164.8.863
   PubMedGoogle Scholar
• Kidambi S, Patel SB. Cholesterol and non-cholesterol sterol transporters: ABCG5, ABCG8 and NPC1L1: a review. Xenobiotica 2008; 38:1119-39; PMID:18668442; http://dx.doi.org/10.1080/00498250802007930
   PubMed Web of Science ®Google Scholar
• Johnson BJ, Lee JY, Pickert A, Urbatsch IL. Bile acids stimulate ATP hydrolysis in the purified cholesterol transporter ABCG5/G8. Biochemistry 2010; 49:3403-11; PMID:20210363; http://dx.doi.org/10.1021/bi902064g
   PubMedGoogle Scholar
• Potthoff MJ, Kliewer SA, Mangelsdorf DJ. Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. Genes Dev 2012; 26:312-24; PMID:22302876; http://dx.doi.org/10.1101/gad.184788.111
   PubMed Web of Science ®Google Scholar
• Wu X, Ge H, Baribault H, Gupte J, Weiszmann J, Lemon B, Gardner J, Fordstrom P, Tang J, Zhou M, et al. Dual actions of fibroblast growth factor 19 on lipid metabolism. J Lipid Res 2013; 54:325-32; PMID:23204296; http://dx.doi.org/10.1194/jlr.M027094
   PubMed Web of Science ®Google Scholar
• Styer AM, Roesch SL, Argyropoulos G. Modulation of fibroblast growth factor 19 expression by bile acids, meal replacement and energy drinks, milk, and coffee. PLoS One 2014; 9:e85558; PMID:24465600; http://dx.doi.org/10.1371/journal.pone.0085558
   PubMedGoogle Scholar
• Kuribayashi H, Miyata M, Yamakawa H, Yoshinari K, Yamazoe Y. Enterobacteria-mediated deconjugation of taurocholic acid enhances ileal farnesoid X receptor signaling. Eur J Pharmacol 2012; 697:132-8; PMID:23051670; http://dx.doi.org/10.1016/j.ejphar.2012.09.048
   PubMed Web of Science ®Google Scholar
• Vassie C, Nolan JD, Johnston IM, Shapiro D, Walters JR. Obeticholic acid, a farnesoid X receptor agonist, reduces bile acid synthesis in patients with primary bile acid diarrhea. Gastroenterology 2014; 146:S-797; PMID:25329562; http://dx.doi.org/10.1016/S0016-5085(14)62881-X
   PubMedGoogle Scholar
• Degirolamo C, Rainaldi S, Bovenga F, Murzilli S, Moschetta A. Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Cell Rep 2014; 7:12-8; PMID:24656817; http://dx.doi.org/10.1016/j.celrep.2014.02.032
   PubMed Web of Science ®Google Scholar
• Begley M, Gahan CGM, Hill C. The interaction between bacteria and bile. Fems Microbiology Reviews 2005; 29:625-51; PMID:16102595; http://dx.doi.org/10.1016/j.femsre.2004.09.003
   PubMed Web of Science ®Google Scholar
• Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 2012; 487:104-8; PMID:22722865; http://dx.doi.org/10.1038/nature11225
   PubMed Web of Science ®Google Scholar
• Vrieze A, Out C, Fuentes S, Jonker L, Reuling I, Kootte RS, Van NE, Holleman F, Knaapen M, Romijn JA, et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J Hepatol 2014; 60:824-31; PMID:24316517; http://dx.doi.org/10.1016/j.jhep.2013.11.034
   PubMed Web of Science ®Google Scholar
• Scherer M, Gnewuch C, Schmitz G, Liebisch G. Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877:3920-5; PMID:19819765; http://dx.doi.org/10.1016/j.jchromb.2009.09.038
   PubMed Web of Science ®Google Scholar
• Matysik S, Klunemann HH, Schmitz G. Gas chromatography-tandem mass spectrometry method for the simultaneous determination of oxysterols, plant sterols, and cholesterol precursors. Clin Chem 2012; 58:1557-64; PMID:22997279; http://dx.doi.org/10.1373/clinchem.2012.189605
   PubMedGoogle Scholar